Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price18.87 USD
Fair value25.93
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-11-01Read Distribution23.63-20.1% to today ✓Markup gives way to Distribution first Distribution read since August
2026-10-11Read Markup24.59-23.3% to today Accumulation gives way to Markup after a 10% rise in 9 days
2026-10-02Read Accumulation22.43-15.9% to today Distribution gives way to Accumulation after a 13% rise in 5 weeks
2026-08-27Read Distribution19.87-5.0% to today ✓Markup gives way to Distribution after an 18% slide in 8 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Enerflex Ltd. holds its Distribution at $18.87. Consolidating, no directional conviction, held for 6 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 6 days
Price at the screen
$18.87
Valuation
32.98 trailing · 10.25 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.93
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
24.28%
Below 33%
Interest-bearing debt is just 24.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
15.22%
Below 49%
Money owed to the company is 15.2% of assets, under the 49% limit.
Pass
Revenue purity
0.16%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Enerflex clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 24%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when EFXT's ethical verdict changes
Today EFXT passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 21% discount to our $25.93 fair value.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 27.2% discount to the base estimate.
Where our models see it going: fair-value estimate $25.93, with a range of $25.93 to $29.82, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cheap Energy Gear Stock Hides A Cyclical Trap
Picture a workshop that builds the pumps and processors for gas fields. When prices are high the orders flood in, yet when they drop the whole place sits half empty. Enerflex fits that pattern exactly. At 11.9 times forward earnings the shares look inexpensive, yet revenue is rising only 6 percent, margins sit at 3 percent and return on equity is a modest 7 percent. Our fair value sits just 2 percent above the current price, so the margin of safety is wafer thin.
We therefore pass. The business clears our ethical screen, but the low multiple in a cyclical sector often signals peak earnings rather than a bargain. Two analysts still rate it a buy with a 32 dollar median target, yet those forecasts rest on sustained energy spending that history shows can reverse quickly.
The real risk is the classic value trap. A modest uptick in orders could lift reported profits for a year or two and then fade, leaving investors with flat returns and tied-up capital. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
EFXT trades on the NYSE (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 209%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (2 analysts) rates it buy, with a mean price target of $30.
2026-10-25Markup$24.69+1.0%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 209%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (2 analysts) rates it buy, with a mean price target of $30.
2026-10-18Markup$24.44-0.6%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 48% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 209%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (2 analysts) rates it buy, with a mean price target of $30.
2026-10-11Markup · changed$24.59+9.6%Entry 7
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 48% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 209%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (2 analysts) rates it buy, with a mean price target of $30.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 12.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 48% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 209%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (2 analysts) rates it buy, with a mean price target of $30.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 15.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 48% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 209%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (2 analysts) rates it buy, with a mean price target of $30.
2026-07-27Markup$23.46-3.5%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 48% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 209%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (2 analysts) rates it buy, with a mean price target of $30.
2026-07-18Markup$24.30+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 48% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 209%. Our forward projection puts the odds of a 10% gain over the next month near 48%. The street (2 analysts) rates it buy, with a mean price target of $30.
2026-07-03Markup$24.30+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$24.30Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
